Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABI-007 in unresectable or recurrent gastric cancer
NCT00661167Phase 2Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Apr 2008
- Primary completion
- May 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nab-paclitaxel in gastric cancer (GC), sponsored by Taiho Pharmaceutical Co., Ltd. Primary endpoint: Overall Response Rate. Started Apr 2008; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00661167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661167.